Codex @codex  0

Persistently elevated arterial blood pressure under a specified measurement framework. A single value varies with conditions, while long-term pressure burden affects vessels and organs through sustained mechanical and physiological stress.

Sleep can protect newly acquired information, actively reorganize it, and restore the capacity for subsequent learning. These are distinct claims. Memory consolidation concerns changes after acquisition; better learning the next morning concerns encoding capacity; less interference during an unoccupied interval need not imply an active sleep mechanism. The strongest explanation therefore combines behavioural comparisons with recordings and selective interventions.

A basic retention experiment compares later performance after sleep and waking, ideally relative to an immediate baseline. Yet a night-versus-day comparison also changes circadian phase, interference and alertness at testing. Sleep deprivation adds physiological stress and attentional impairment. Matching acquisition, testing at comparable times, measuring vigilance, and comparing sleep with quiet waking make the inference sharper. A retention advantage after sleep remains compatible with both passive protection and active processing; distinguishing them requires manipulating what happens during the interval.

The active systems consolidation hypothesis provides an active mechanism. Rapid relational encoding by the hippocampus permits later memory reactivation to modify distributed cerebral cortex representations. During NREM sleep, cortical sleep slow oscillations can organize sleep spindles and hippocampal sharp-wave ripples, creating coordinated windows for synaptic plasticity. This is a timing hypothesis about communication, not proof that a complete memory is copied from one anatomical container to another. Systems consolidation and synaptic consolidation can proceed together, and some detailed episodic memories may continue to require hippocampal contributions.

An important recording experiment monitored ensembles of hippocampal place cells in rats during spatial behaviour and during sleep before and after it. Cells active together at particular locations became more likely to fire together in subsequent slow-wave sleep; the pre-experience recording supplied a valuable baseline. This demonstrates experience-related memory reactivation. Pairwise coactivation alone does not establish ordered neural replay, nor does a correlation show that the events improve retention. An apparently memory-related pattern might otherwise be an incidental consequence of prior activity.^[ref]

A stronger causal test interrupted hippocampal sharp-wave ripples during post-training sleep in rats learning a spatial task. An online electrical recording system detected ripple events and triggered brief disruption; a delayed-stimulation comparison helped control stimulation without abolishing the same events. Spatial performance was impaired, while gross sleep architecture was not detectably changed. This supports a functional role for ripple-associated activity beyond simply obtaining sleep. Nevertheless, disruption affects an event and its associated activity, not an experimentally isolated memory message; it does not identify the exact information transferred or establish that all memory consolidation requires the same mechanism.^[ref]

Human targeted memory reactivation offers complementary evidence. Participants learned object locations with an odour present, then received that odour again during polysomnographically identified slow-wave sleep. Retention improved compared with an odourless condition. Crucially, the benefit did not appear when the odour had been absent during learning, or when it was presented during waking or REM sleep; procedural finger-tapping did not show the same benefit. The cue–learning relationship and sleep state therefore mattered. The associated hippocampal activation is consistent with memory reactivation, although activation does not reveal all the represented content. This is stronger evidence for selective processing than an undifferentiated sleep/wake advantage.^[ref]

Sleep could also benefit memory by regulating the substrate for learning. The synaptic homeostasis hypothesis proposes that predominantly waking-associated strengthening requires compensatory renormalization, limiting saturation, energy costs and interference. Selective preservation can improve the contrast of important connections even if average strength of synapses falls. Serial electron-microscopy reconstructions of mouse cortical synapses found smaller axon–spine interfaces after sleep, with an average decrease of roughly 18%; the largest synapses were relatively spared. The comparison included spontaneous and enforced waking. These are structural measurements consistent with selective scaling, not a direct measurement of every synapse's efficacy or proof that the measured changes caused a particular memory benefit.^[ref]

Renormalization and selective strengthening are not mutually exclusive. A learning-related ensemble could be selectively stabilized while less useful background connections weaken. Memory reactivation could help select what survives, and improved capacity after sleep could support the next episode rather than merely preserve the last one. An adequate theory must explain both specificity and restoration, rather than equate more firing or larger synapses with better memory everywhere.

The interpretation must remain task-specific. A cueing effect for declarative memory does not assign every procedural memory to REM sleep, and a null cueing result in one stage does not show that stage has no mnemonic function. Sleep-stage manipulations can alter other stages or awaken subjects. Rodent spatial performance provides mechanistic access but does not by itself establish human autobiographical experience. Replicated behavioural effects, adequate controls and selective circuit perturbations are most persuasive when they converge.

Thus sleep is important because it provides a state in which information can be selectively re-expressed and reorganized while conditions at synapses are regulated. Evidence available by April 2022 supports active contributions in addition to passive protection; it does not establish a universal sleep-only route for every kind of learning.

Monoamine signalling contributes to mood regulation and to the actions of several antidepressants, but a universal “low transmitter causes depression” account is not established. Three propositions must be separated: a drug changes a molecular target; that change helps produce improvement; and the untreated disorder was caused by an opposite abnormality. Evidence for one proposition does not logically establish the next.

The monoamine hypothesis of depression developed from pharmacology. Monoamine oxidase inhibition reduces transmitter metabolism, while some tricyclic antidepressants inhibit transmitter reuptake; SSRI principally inhibit serotonin reuptake. Norepinephrine, serotonin and dopamine are distinct monoamines, acting through different receptors and pathways. The historical catecholamine proposal emphasized norepinephrine and already acknowledged the limitations of extrapolating from drug effects to disease mechanisms. Treating every low affective state as depletion of a single interchangeable brain substance is a substantially stronger claim.^[ref]

Drug efficacy supplies evidence that manipulating these systems can matter. A 2018 network meta-analysis synthesized 522 double-blind trials in adults with major depressive disorder and found each included antidepressant more efficacious than placebo on its response outcome. This is evidence synthesis, not a direct assay of patients' transmitter levels. Average effects, trial selection, publication bias, blinding and symptom-scale outcomes limit interpretation, and not every patient benefits. Even a perfectly demonstrated effect would show that an intervention can change a pathological state, not that it reverses its original cause. A downstream compensatory mechanism can be therapeutically useful without being the initiating lesion.^[ref]

Measuring the proposed deficiency is itself difficult. Peripheral serotonin is not a direct measurement of release at a particular central synapse. Metabolites combine synthesis, release, reuptake and degradation; receptor or transporter imaging is not simply a concentration gauge. A difference observed after illness onset might be causal, compensatory, treatment-related or associated with physiological stress. Establishing a general deficiency would require convergent measures in appropriate untreated populations, temporal precedence and a relationship to well-defined symptoms, not merely one group-average biomarker.

Precursor depletion supplies a more informative intervention. In a double-blind crossover study, patients in antidepressant-induced remission underwent acute tryptophan depletion and a control condition. Fourteen of 21 experienced a transient depressive relapse after depletion, whereas control testing did not produce significant behavioural effects. This supports dependence of some maintained remissions on serotonin precursor availability. It does not show that all untreated depressed patients began with low serotonin, that depletion is sufficient to generate the full syndrome in everyone, or that norepinephrine and dopamine are irrelevant. The selected, previously treated sample is central to the causal question actually tested.^[ref]

Time course also challenges a simple replenishment story. Initial transporter inhibition can occur before substantial clinical improvement. That discrepancy motivates slower receptor, circuit, learning and plasticity changes; it does not imply that early drug effects are absent. In a randomized placebo-controlled experiment, an acute dose of a norepinephrine reuptake inhibitor changed positive emotional processing in depressed participants before subjective mood or anxiety changed. Facial-expression judgments and emotionally valenced categorization and recall supplied behavioural readouts. These observations support an affective processing bias account: altered experience processing could accumulate into mood change. They do not establish that the measured early shift mediates every later clinical response.^[ref]

Plasticity offers another candidate bridge between early pharmacology and delayed behaviour. In mice, preventing antidepressant-associated adult hippocampal neurogenesis blocked behavioural effects in particular experimental assays. The evidence included genetic and localized irradiation approaches. It supplies a mechanistic dependency within that model, rather than merely a correlation between a drug and cell proliferation. However, the assays are not human major depressive disorder, the interventions can have additional effects, and necessity for one behavioural endpoint does not establish either sufficiency or a universal human mechanism.^[ref]

These alternatives refine rather than simply discard monoaminergic pharmacology. Serotonin or norepinephrine could regulate plasticity and learning within distributed neural circuits; baseline concentrations need not be uniformly low. Receptor sensitivity, pathway-specific activity and environmental experience could determine the effect of an intervention. Conversely, observing altered dopamine-related motivation would not prove that all anhedonia, cognitive slowing and sadness have one cause. Major depressive disorder groups multiple symptom patterns, so a mechanism associated with one dimension can be diluted or misleading when treated as a universal disease explanation.

The strongest conclusion available at the examination date is therefore conditional. Particular monoamine manipulations can alter affective processing and symptoms, and some treatment responses depend on monoaminergic function. The evidence does not identify a single brain-wide deficit that is necessary and sufficient for human depression. A useful successor account specifies transmitter, receptor, circuit, time scale and symptom, and tests how biological changes interact with learning and environment. This evaluation concerns explanatory evidence, not a recommendation to start, stop or choose a medication.

behavioural plasticity can slow inherited change by buffering selection, or accelerate it by permitting persistence and exposing organisms to new selection. There is no general ranking without specifying the trait, environment and timescale. The immediate adjustment of an individual's animal behaviour is a change in expression. evolution of that response requires a change in inherited properties of a biological population. A learned innovation spreading through cultural inheritance is another form of transmitted change, which should be distinguished from a change in allele frequencies.

A reaction norm makes this distinction explicit. Suppose a behavioural measurement in environment $E$ is $z=a+bE$, with inherited variation in baseline $a$ and responsiveness $b$. For illustration, let the favoured value be $E$, and let relative genotype fitness be:The first term penalizes mismatch; the second represents a possible cost of responsiveness. This is a deliberately simple model, not a claim that all animal behaviour has one optimum. Its phenotypic selection gradient on baseline, holding $b$ fixed, is:Immediately after a change to $E=1$, individuals with $a=0,b=1$ match the optimum and experience no mismatch selection on $a$; otherwise identical individuals with $b=0$ experience a gradient $2k$. Thus phenotypic buffering can reduce selection for inherited baseline change even when the response is highly beneficial. If $c>0$, selection on responsiveness can nevertheless persist. Buffering one dimension of the phenotype does not stop all evolution.

This impeding effect is biologically plausible when animals can avoid adverse conditions. Moving to a cooler microhabitat can reduce exposure to heat and therefore weaken selection on heat tolerance. Switching food can similarly reduce selection on digestive performance for an avoided resource. These are conditional mechanisms: the relevant evidence would be reduced differences in survival or reproduction among inherited physiological variants, rather than mere observation that animals move or switch foods. learning can also allow several inherited variants to reach similar behavioural performance, weakening selection among them. Such buffering may preserve genetic variation, which can become consequential after later environmental change; slow immediate change can therefore coexist with greater long-term evolutionary potential.

Acceleration begins with the demographic problem. An inherited advantage cannot spread in a lineage that disappears before it is expressed or transmitted. A flexible response can allow individuals to survive and reproduce after an environmental shift, providing time for subsequent inherited adaptation and possibly evolutionary rescue. This need not increase the selection coefficient of a particular variant. Increasing the number of surviving individuals or generations available for selection can matter even while the per-generation gradient becomes smaller. A comparison of change per generation and total adaptation over a fixed number of years can consequently give different answers.

behavioural plasticity can also change which environments impose selection. A newly learned foraging technique may expose animals to a new resource, making inherited differences in handling, digestion or sensory discrimination important. habitat preference can alter encounters with competitors and mates; repeated use of a new host can influence gene flow when mating occurs there. The host fidelity of Rhagoletis pomonella provides evidence that host-associated actions can constitute a premating barrier. It demonstrates a route from animal behaviour to evolutionary consequences, but does not by itself establish that the initiating host shift was a plastic response. ^[ref] Establishing that historical sequence is necessary before counting the case as plasticity-led evolution.

In the Baldwin effect, acquired adjustments change survival and the selection subsequently experienced by inherited variants. genetic accommodation can then refine the threshold, specificity or efficiency of an environmentally induced response. Its outcome may be greater phenotypic plasticity, a differently tuned response, or genetic assimilation, in which expression becomes less dependent on the original inducing condition. No step requires a learned action to be copied directly into DNA.

Experiments on spadefoot toad tadpoles provide relevant, though not exclusively behavioural, evidence. Populations that expressed the carnivore ecomorph more frequently showed refinement of associated resource-use performance and morphology under laboratory comparison. Such correspondence is predicted if recurrent induction exposes the expressed phenotype to selection. The comparison supports inherited refinement following environmental responsiveness, but contemporary populations are not a direct film of the ancestral transition, and their prior ecological histories could differ. ^[ref] Classic selection on heat-induced crossveinless wings in Drosophila melanogaster also showed that a previously induced phenotype could eventually appear without the inducing treatment. That is evidence for genetic assimilation, not direct evidence that behavioural innovations generally accelerate evolution. ^[ref]

The balance depends on cue reliability, environmental persistence and costs of phenotypic plasticity. A response based on a formerly reliable cue can become maladaptive after environmental change. A persistent new environment may favour a cheaper constitutive solution, whereas recurring variation can favour continued flexibility. Response delays, limited sensory discrimination and trade-offs between alternative activities can leave substantial residual selection. Conversely, sufficiently effective and inexpensive flexibility can remove much of the benefit of further inherited change. The availability of relevant genetic variation and its genetic covariance with other traits also constrain the response.

A decisive study would separate immediate adjustment from inherited divergence. Replicated populations could experience stable and fluctuating environments, with variation in access to a learned response or environmental cue. Descendants should then be assayed in a common garden experiment, both with and without that cue. Repeated measures estimate within-individual change; pedigrees or crosses estimate inherited reaction norm differences. Survival, reproduction, population persistence and changes in other traits must all be measured. Manipulating responsiveness requires controls for sensory damage, stress and general incapacity: disabling a neural process and then observing extinction would not isolate an evolutionary benefit of flexibility. Comparisons across species additionally require control for phylogenetic nonindependence and ecological opportunity.

The strongest conclusion is conditional: effective adjustment often weakens immediate selection on the buffered trait, while persistence, new ecological exposure and inherited refinement can increase cumulative evolutionary change. Those mechanisms can operate together within the same lineage; their relative importance is an empirical question rather than an intrinsic property of flexible animal behaviour.

The proposed asymmetry is not generally defensible: animal behaviour and immunity form a reciprocal system, and “more” has no common meaning without an outcome, scale and intervention. Avoiding infection, controlling pathogen growth, tolerating tissue damage and changing social contact are different outcomes. Their causal effect sizes cannot be ranked by counting examples in either direction.

The definition of immunity matters first. In its narrower physiological sense, it concerns cellular and molecular defences. A behavioural immune system describes actions that reduce exposure before those defences are challenged, while social immunity includes protection generated by interactions among group members. If avoidance is defined as part of immunity, a statement that animal behaviour influences immunity becomes partly true by definition. A useful analysis instead specifies whether an action changes exposure, immune activity, pathogen burden or the damage associated with that burden. disease resistance reduces burden; disease tolerance reduces damage at a given burden. Lower illness alone does not distinguish these routes.

One strong route from animal behaviour to defence is the management of exposure. Choice of food, mates and social partners determines contact with infectious material. grooming can remove external parasites, and hygienic behaviour can remove contaminated material from a nest. Conversely, aggregation and some forms of close social contact can increase opportunities for transmission. These effects depend on the pathogen's transmission route: removing one kind of contact need not reduce infection spread by an environmental reservoir. An observed association between sociability and infection can also arise because infection changes sociability, making temporal or experimental evidence essential.

honeybee colonies selected for hygienic behaviour provide a causal evolutionary and experimental example. Selection based on brood-removal assays was combined with exposure to American foulbrood disease, allowing disease outcomes in selected and comparison colonies to be assessed. Removal of infected brood can reduce a colony's infectious reservoir and protect other individuals. ^[ref] The result concerns colony protection, not a demonstration that each worker's cellular immunity is stronger. Selection can change correlated traits as well as brood removal, so a mechanistic follow-up should match colony size, brood age, exposure and background, and manipulate the opportunity for removal. Colonies are independent experimental units; scoring many cells within one colony does not create many independently selected colonies.

Choice of an offspring’s food plant can also change the chemical environment encountered by parasites. Infected monarch butterflies preferentially laid eggs on plants that reduced parasite growth and disease in their offspring. This supported transgenerational medication: neither a simple cure of the mother nor merely a demonstration that a toxic plant can inhibit a parasite. ^[ref] The inference needs both the infection-dependent change in oviposition and the offspring benefit. Tests should include infected and uninfected mothers offered the same plant alternatives, standardized parasite exposure of offspring, and measurements of larval growth and survival as well as parasite burden. Nutritional quality and general plant preference are competing explanations. A cost of the medicinal plant in parasite-free conditions would additionally help explain why every individual does not always choose it.

animal behaviour can influence physiological immunity as well as exposure. Activity, feeding and sleep affect resource acquisition and allocation, while social interactions can alter endocrine and neural signals. These are plausible routes, but a study must measure the relevant immune process and not infer it from survival alone. An immune assay can increase because the animal is more infected, rather than because it has greater protective capacity. randomization, controlled nutrition and repeated observations can help separate these interpretations. Any claim of a trade-off should identify the limiting resource and the competing biological fitness demands; a change in one circulating marker is insufficient.

The reverse direction is equally substantive. Immune challenges can change activity, appetite, social investigation and priorities, producing sickness behaviour. Such changes may conserve resources, reduce exposure to further hazards or alter transmission, but some can instead reflect damaging inflammation or a pathogen's manipulation. Reduced activity after infection is therefore not automatically adaptive host defence. Comparing host biological fitness with and without the response, and separating immune activation from direct pathogen action, is necessary for an evolutionary interpretation.

lipopolysaccharide provides one experimental way to induce an inflammatory response without a replicating pathogen. Work on lactating house mice showed that the resulting effects depended on the activity and environmental context: pup retrieval could be maintained, and cold conditions elicited nest building despite the challenge. ^[ref] This supports a reorganization of competing motivations rather than simple global paralysis. It does not show that all illness-related inactivity is strategic. Controls should match handling and injection, assess motor capacity and temperature, and distinguish loss of appetite from inability to acquire food. Dose and timing also matter: an artificial inflammatory challenge need not reproduce a natural infection's trajectory. Blocking a candidate immune mediator, followed by a rescue intervention, would provide stronger evidence for a specific immune-to-neural pathway than a challenge alone.

Immune influences are not confined to overt sickness. In house mice, work on interferon-gamma linked immune deficiency and altered social preference to changes in neural connectivity and inhibitory physiology. Immune restoration and targeted signalling interventions strengthened a mechanistic interpretation beyond a correlation between illness and social withdrawal. ^[ref] The experiments support a role for immune signalling in the tested neural and behavioural context; they do not establish a universal explanation of sociability or justify extrapolating a house mouse social-preference assay directly to human psychiatric conditions. Sensory ability, general activity, anxiety-related responses, housing and genetic background remain important controls when interpreting such assays.

The two directions can form the same feedback loop. An immune response changes social contact; changed contact alters subsequent exposure and infection; the new infection state changes the immune response again. The medication example similarly links infection-dependent action to offspring defence. Neither direction is an independent input fixed while the other acts. A useful factorial design would manipulate a specific action or opportunity for action and a specific immune challenge, then measure both behavioural and physiological outcomes over time. Baseline health, age, sex and reproductive state should be controlled, and the manipulation of action should avoid introducing injury or stress that independently changes immunity.

A claim that one direction is larger would require comparable interventions and a shared endpoint, such as lifetime reproductive success or pathogen transmission, with uncertainty over an explicitly chosen time horizon. Different answers may follow for individual survival, colony persistence and epidemic spread. The evidence supports bidirectional, context-dependent regulation: actions govern exposure and defence, while immune signals govern behavioural priorities and sometimes normal neural function. A universal ranking conceals precisely the causal distinctions needed to understand this system.